ML Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ML Pharma
Largest movements
- Cash -€34,734
down €34,734 (-25.7%), from €135,409 to €100,675
mainly Debts after one year (-€68,577) and Other debts (-€50,440)
- Intangible fixed assets -€26,000
down €26,000 (-12.5%), from €208,000 to €182,000
- Receivables within one year +€17,918
up €17,918 (+17.2%), from €104,012 to €121,930
of which Other amounts receivable: +€15,143
- Tangible fixed assets -€14,930
down €14,930 (-13.7%), from €108,917 to €93,987
- Stocks and contracts -€11,637
down €11,637 (-14.0%), from €83,321 to €71,684
- Debts after one year -€68,577
down €68,577 (-34.2%), from €200,433 to €131,856
- Other debts -€50,440
down €50,440 (-50.8%), from €99,324 to €48,884
- Trade debts +€17,695
up €17,695 (+12.5%), from €141,455 to €159,150
- Tax, wage and social debts +€16,196
up €16,196 (+78.1%), from €20,730 to €36,927
of which Remuneration and social security: +€13,937
- Profit (loss) carried forward +€13,058
up €13,058 (+13.2%), from €99,260 to €112,318
- Staff costs +€46,098
up €46,098 (+51.1%), from €90,270 to €136,369
- Gross operating margin -€28,472
down €28,472 (-11.9%), from €239,806 to €211,334
- Taxes -€19,542
down €19,542 (-77.5%), from €25,212 to €5,670
- Financial charges -€2,611
down €2,611 (-16.0%), from €16,348 to €13,737
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €643,247 | €573,903 | -€69,344 | -10.8% |
| Fixed assets | 21/28 | €316,917 | €275,987 | -€40,930 | -12.9% |
| Intangible fixed assets | 21 | €208,000 | €182,000 | -€26,000 | -12.5% |
| Tangible fixed assets | 22/27 | €108,917 | €93,987 | -€14,930 | -13.7% |
| Furniture and vehicles | 24 | €108,917 | €93,987 | -€14,930 | -13.7% |
| Current assets | 29/58 | €326,330 | €297,916 | -€28,414 | -8.7% |
| Stocks and contracts in progress | 3 | €83,321 | €71,684 | -€11,637 | -14.0% |
| Stocks | 30/36 | €83,321 | €71,684 | -€11,637 | -14.0% |
| Amounts receivable within one year | 40/41 | €104,012 | €121,930 | +€17,918 | +17.2% |
| Trade receivables | 40 | €104,012 | €106,787 | +€2,775 | +2.7% |
| Other amounts receivable | 41 | - | €15,143 | +€15,143 | |
| Cash at bank and in hand | 54/58 | €135,409 | €100,675 | -€34,734 | -25.7% |
| Deferred charges and accrued income | 490/1 | €3,589 | €3,628 | +€39 | +1.1% |
| Total equity and liabilities | 10/49 | €643,247 | €573,903 | -€69,344 | -10.8% |
| Equity | 10/15 | €109,260 | €122,318 | +€13,058 | +12.0% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €99,260 | €112,318 | +€13,058 | +13.2% |
| Amounts payable | 17/49 | €533,987 | €451,585 | -€82,402 | -15.4% |
| Amounts payable after more than one year | 17 | €200,433 | €131,856 | -€68,577 | -34.2% |
| Financial debts | 170/4 | €200,433 | €131,856 | -€68,577 | -34.2% |
| Amounts payable within one year | 42/48 | €332,325 | €318,897 | -€13,427 | -4.0% |
| Current portion of amounts payable after more than one year | 42 | €70,815 | €73,937 | +€3,122 | +4.4% |
| Trade debts | 44 | €141,455 | €159,150 | +€17,695 | +12.5% |
| Suppliers | 440/4 | €141,455 | €159,150 | +€17,695 | +12.5% |
| Taxes, remuneration and social security | 45 | €20,730 | €36,927 | +€16,196 | +78.1% |
| Taxes | 450/3 | €10,475 | €12,734 | +€2,259 | +21.6% |
| Remuneration and social security | 454/9 | €10,255 | €24,192 | +€13,937 | +136% |
| Other amounts payable | 47/48 | €99,324 | €48,884 | -€50,440 | -50.8% |
| Accrued charges and deferred income | 492/3 | €1,230 | €832 | -€398 | -32.4% |
| Remuneration, social security and pensions | 62 | €90,270 | €136,369 | +€46,098 | +51.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €40,518 | €40,930 | +€412 | +1.0% |
| Other operating charges | 640/8 | €599 | €737 | +€138 | +23.1% |
| Gross operating margin | 9900 | €239,806 | €211,334 | -€28,472 | -11.9% |
| Operating profit (loss) | 9901 | €108,420 | €33,298 | -€75,121 | -69.3% |
| Financial charges | 65/66B | €16,348 | €13,737 | -€2,611 | -16.0% |
| Recurring financial charges | 65 | €16,348 | €13,737 | -€2,611 | -16.0% |
| Profit (loss) for the period before taxes | 9903 | €92,071 | €19,561 | -€72,510 | -78.8% |
| Income taxes | 67/77 | €25,212 | €5,670 | -€19,542 | -77.5% |
| Profit (loss) for the period | 9904 | €66,859 | €13,891 | -€52,968 | -79.2% |
| Profit (loss) for the period to be appropriated | 9905 | €66,859 | €13,891 | -€52,968 | -79.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.